RESEARCHER PROFILE

М. М. Батюшин

← Back to Rostov State Medical University

Rostov State Medical University

Chronic Kidney Disease and DiabetesRenal Diseases and GlomerulopathiesDialysis and Renal Disease ManagementAcute Kidney Injury ResearchRenal and Vascular Pathologies

М. М. Батюшин works in Chronic Kidney Disease and Diabetes, Renal Diseases and Glomerulopathies, Dialysis and Renal Disease Management, Acute Kidney Injury Research, Renal and Vascular Pathologies. Recorded institutional associations include Rostov State Medical University, Ministry of Health of the Russian Federation.

107Publications

713Citations

7H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

М. М. Батюшин

Rostov State Medical University

Selected research works

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Prevalence of chronic kidney disease according to the retrospective cohort study “CKD epidemiology” (Kirov City)

The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2

Chronic Kidney Disease: Current State of the Problem

Monocyte chemoattractant protein-1: its role in the development of tubulointerstitial fibrosis in nephropathies

Применение КОВИД-глобулина в терапии COVID-19

PROFESSOR ALEXANDER I. IGNATOWSKI A FOUNDER OF THE THEORY OF ATHEROSCLEROSIS

Renal service during the COVID-19 pandemic (Association of nephrologists position statement)

Impact of Kidney Damage on the Course and Prognosis of COVID-19 Infection According to the International Registry «Analysis of Chronic Non-Infectious Diseases Dynamics After Covid-19 Infection in Adult Patients»

Uromodulin — Biological Significance and Prospects for Clinical Use

Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts

Complex Assessment of Risk Factors for the Development of Cardiovascular Calcification in Hemodialysis Patients

Risk of Cardiovascular Death in the Remote Period after Myocardial Revascularization and in Association with Renal Dysfunction

7-(1-Methyl-3-Pyrrolyl-)-4,6-Dinitrobenzofuroxan Reduces the Frequency of Antibiotic Resistance Mutations Induced by Ciprofloxacin in Bacteria

ВЗАИМОСВЯЗЬ MCP-1 И ТУБУЛОИНТЕРСТИЦИАЛЬНОГО ФИБРОЗА ПРИ ХРОНИЧЕСКОМ ГЛОМЕРУЛОНЕФРИТЕ

THE RELATIONSHIP OF MCP-1 AND TUBULOINTERSTITIAL FIBROSIS IN CHRONIC GLOMERULONEPHRITIS

PROGNOSTIC VALUE OF RENAL DYSFUNCTION AND THE IMBALANCE OF BODY AQUATIC ENVIRONMENTS IN PATIENTS WITH ACUTE CORONARY PATHOLOGY

The prevalence of asymptomatic hyperuricemia in patients with chronic kidney disease and its effect on the course and prognosis (experience of one center)

Management of arterial hypertension in patients with chronic kidney disease on hemodialysis

The Search for Molecular Prognostic Markers of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

Factor Analysis of Predicting Cardiovascular Death in the Remote Period after Myocardial Revascularization

ПРОБЛЕМЫ БИОСОВМЕСТИМОСТИ ДИАЛИЗНОЙ ТЕРАПИИ